Movement disorders clinical practice · 2025
VPS16-Related Dystonia: Expanding the Clinical Spectrum and Therapeutic Insights.
СтатьяКлинический случайОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Panigrahi Baikuntha, Radhakrishnan Divya Madathiparambil, Saini Arti, Garg Divyani, Rajanna Chaitra, Aliyar Aminu, Siripurapu Govinda, Das Animesh, Elavarasi A, Agarwal Ayush, Gupta Anu, Pandit Awadh Kishor, Vishnu Venugopalan Yamuna, Singh Mamta Bhushan, Bhatia Rohit, Kumar Rajinder, Srivastava Achal Kumar, Rajan Roopa
Аннотация
BACKGROUND: DYT-VPS16 is a rare monogenic form of dystonia caused by pathogenic variants in the vacuolar protein sorting 16 homolog (VPS16) gene. Although increasingly recognized, the clinical spectrum and therapeutic responsiveness, particularly to deep brain stimulation (DBS), remain incompletely defined.
CASES: We report six affected individuals (5 males, 1 female) from five unrelated Indian families harboring VPS16 variants. The median age at onset was 16.5 years (range, 8-18 years). Dystonia began in the cervical (n = 2), upper limb (n = 2), or laryngeal (n= 2) regions. Additional features included tremor (n = 2) and sleep disturbances (n = 1).
LITERATURE REVIEW: A structured literature review identified 34 previously reported DYT-VPS16 cases treated with DBS. Pooled analysis revealed a responder rate (defined as ≥30% improvement in BFMDRS-M) of 0.57 (95% CI: 0.31-0.81; I2 = 22.9%) suggesting a favorable therapeutic response in this subgroup.
CONCLUSION: Our findings broaden the genotypic and phenotypic landscape of DYT-VPS16, suggesting a more motor-predominant and potentially milder expression in South Asian patients. DBS appears to confer meaningful clinical benefit in selected cases, highlighting the importance of early genetic diagnosis in guiding treatment.
CASES: We report six affected individuals (5 males, 1 female) from five unrelated Indian families harboring VPS16 variants. The median age at onset was 16.5 years (range, 8-18 years). Dystonia began in the cervical (n = 2), upper limb (n = 2), or laryngeal (n= 2) regions. Additional features included tremor (n = 2) and sleep disturbances (n = 1).
LITERATURE REVIEW: A structured literature review identified 34 previously reported DYT-VPS16 cases treated with DBS. Pooled analysis revealed a responder rate (defined as ≥30% improvement in BFMDRS-M) of 0.57 (95% CI: 0.31-0.81; I2 = 22.9%) suggesting a favorable therapeutic response in this subgroup.
CONCLUSION: Our findings broaden the genotypic and phenotypic landscape of DYT-VPS16, suggesting a more motor-predominant and potentially milder expression in South Asian patients. DBS appears to confer meaningful clinical benefit in selected cases, highlighting the importance of early genetic diagnosis in guiding treatment.